CRIP3
Cysteine-rich protein 3
Also known as: bA480N24.2, CRIP3_HUMAN, TLP, TLP-A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6Q6R5
- Gene
- CRIP3
- Ensembl
- ENSG00000146215
- Chromosome
- 6
- Canonical length
- 217 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
Predicted to enable metal ion binding activity. Predicted to act upstream of or within T cell proliferation. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
217 residues, UniProt reviewed canonical sequence.
>Q6Q6R5|CRIP3
1 MSWTCPRCQQ PVFFAEKVSS LGKNWHRFCL KCERCHSILS PGGHAEHNGR PYCHKPCYGA
61 LFGPRGVNIG GVGSYLYNPP TPSPGCTTPL SPSSFSPPRP RTGLPQGKKS PPHMKTFTGE
121 TSLCPGCGEP VYFAEKVMSL GRNWHRPCLR CQRCHKTLTA GSHAEHDGVP YCHVPCYGYL
181 FGPKGGQPHP RHWDGMYMPE VWHVHGLWVC VDNFPCGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRIP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- testis: 25 nTPM
- heart muscle: 23 nTPM
- cerebellum: 15 nTPM
- basal ganglia: 9.8 nTPM
- liver: 9.5 nTPM
- spleen: 7.8 nTPM
Single-cell type
- late spermatids: 14 nCPM
- cardiomyocytes: 8.1 nCPM
- astrocytes: 7.2 nCPM
- late primary spermatocytes: 7.2 nCPM
- oligodendrocyte progenitor cells: 7.2 nCPM
- bergmann glia: 5.9 nCPM
Immune cell
- myeloid DC: 45 nTPM
- classical monocyte: 2.7 nTPM
- naive B-cell: 2.6 nTPM
- memory B-cell: 2.3 nTPM
- non-classical monocyte: 2.3 nTPM
- total PBMC: 1.8 nTPM
Brain region
- cerebellum: 8.1 nTPM
- hypothalamus: 6.6 nTPM
- cerebral cortex: 6.3 nTPM
- white matter: 6 nTPM
- basal ganglia: 5.7 nTPM
- hippocampal formation: 5.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.06
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRIP3 as an antibody target. Whether an autoantibody or antibody against CRIP3 could matter depends on whether native CRIP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRIP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRIP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...